Development of Postoperative Bronchopleural Fistula after Neoadjuvant Immunochemotherapy in Nonsmall Cell Lung Cancer: Case Reports

被引：0
|
作者：
Ma, K. [1 ]
Wang, X. [1 ]
Zhao, S. R. [1 ]
Sun, C. [1 ]
Xu, H. Y. [1 ]
Zhang, P. [1 ]
Liu, P. Y. [1 ]
Lin, Y. X. [1 ]
Qiu, S. [1 ]
Guo, Y. [1 ]
Yang, G. Z. [1 ]
Shao, G. G. [1 ]
机构：
[1] First Hosp Jilin Univ, Changchun, Peoples R China
来源：
JOURNAL OF THORACIC ONCOLOGY | 2023年 / 18卷 / 11期
关键词：
Bronchopleural fistula; Non-small-cell lung cancer; neoadjuvant chemoimmunotherapy;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P2.07-01
引用
收藏
页码：S322 / S323
页数：2
相关论文
共 50 条
  • [31] Bronchopleural fistula after pneumonectomy for lung cancer: Consideration of 450 consecutive cases
    Mossetti, C
    Lausi, R
    Ardissone, F
    Manzone, E
    Selvaggi, G
    Novello, S
    Borasio, P
    LUNG CANCER, 2005, 49 : S356 - S356
  • [32] Induction Immunochemotherapy Before Definitive Chemoradiotherapy for Patients with Stage III NonSmall Cell Lung Cancer
    Zheng, S.
    Sun, C.
    Zhang, H.
    Dong, B.
    Hou, Z.
    Chen, M.
    Li, Q.
    JOURNAL OF THORACIC ONCOLOGY, 2024, 19 (10) : S583 - S583
  • [33] The Development of Bronchopleural Fistula in Lung Cancer Patients after Major Surgery: 31 Years of Experience with 19 Cases
    Uramoto, Hidetaka
    Hanagir, Takeshi
    ANTICANCER RESEARCH, 2011, 31 (02) : 619 - 624
  • [34] Conservatively Managed Chronic Bronchopleural Fistula After Lung Cancer Tri-Modality Therapy: A Case Report
    Haldar, Nilanjan
    Fernandez, Christian
    Evans, Nathaniel R.
    Werner-Wasik, Maria
    ADVANCES IN RADIATION ONCOLOGY, 2022, 7 (01)
  • [35] THE CASE FOR MITOMYCIN IN NONSMALL CELL LUNG-CANCER
    SPAIN, RC
    ONCOLOGY, 1993, 50 : 35 - 52
  • [36] A Clinical Risk Model for the Evaluation of Bronchopleural Fistula in Non-Small Cell Lung Cancer After Pneumonectomy
    Hu, Xue-fei
    Duan, Liang
    Jiang, Ge-ning
    Wang, Hao
    Liu, Hong-cheng
    Chen, Chang
    ANNALS OF THORACIC SURGERY, 2013, 96 (02): : 419 - 424
  • [37] Neoadjuvant chemotherapy and Avelumab in early stage resectable nonsmall cell lung cancer
    Tfayli, Arafat
    Al Assaad, Majd
    Fakhri, Ghina
    Akel, Reem
    Atwi, Hanine
    Ghanem, Hady
    El Karak, Fadi
    Farhat, Fadi
    Al Rabi, Kamal
    Sfeir, Pierre
    Youssef, Pierre
    Mansour, Ziad
    Assi, Hazem
    Haidar, Mohamad
    Abi Ghanem, Alain
    Khalifeh, Ibrahim
    Boulos, Fouad
    Mahfouz, Ramy
    Youssef, Bassem
    Zeidan, Youssef
    Bejjany, Rachelle
    Khuri, Fadlo
    CANCER MEDICINE, 2020, 9 (22): : 8406 - 8411
  • [38] VINORELBINE (NAVELBINE) IN THE ADJUVANT AND NEOADJUVANT TREATMENT OF NONSMALL CELL LUNG-CANCER
    VIALLET, J
    AYOUB, J
    ROUSSEAU, P
    SOUHAMI, L
    HOHNEKER, J
    SHEPHERD, F
    SEMINARS IN ONCOLOGY, 1994, 21 (05) : 64 - 72
  • [39] Neoadjuvant therapy with immune checkpoint inhibitors in operable nonsmall cell lung cancer
    Huber, Rudolf M.
    CURRENT OPINION IN ONCOLOGY, 2024, 36 (01) : 29 - 34
  • [40] Combination of neoadjuvant and adjuvant chemotherapy in nonsmall cell lung cancer: Is it possible and effective?
    Kolek, Vitezslav
    Grygarkova, Ivona
    Hajduch, Marian
    Klein, Jiri
    Neoral, Cestimir
    CHEST, 2006, 130 (04) : 89S - 90S
12345